Highnoon Laboratories Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Highnoon Laboratories Limited with three other
pharmaceutical manufacturers in Asia:
Mangalam Drugs & Organics Limited
sales of 2.95 billion Indian Rupees [US$45.93 million]
Samsung Pharmaceutical Co Ltd
of South Korea
(48.22 billion Korean Won [US$45.19 million]
Sinil Pharmaceutical Co Ltd
based in South Korea
(50.21 billion Korean Won [US$47.05 million]
Highnoon Laboratories Limited reported sales of 5.07 billion Pakistan Rupees (US$45.79 million)
December of 2016.
increase of 15.1%
versus 2015, when the company's sales were 4.40 billion Pakistan Rupees.
This was the fourth straight year of sales growth at Highnoon Laboratories Limited.